樂觀
$128.92
情境價格
$119.970
+1.956 (+1.63%)收盤時
Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance.
Aflac Inc is a good buy right now due to its strong recent performance with a current price of $119.97 and a significant 5-day change of +4.74%. The RSI is at 83.88, indicating strong momentum, while the forward P/E ratio is 15.20, suggesting reasonable valuation compared to growth expectations. However, the main risk is the downgrade from Mizuho, reducing the price target to $107, indicating potential downside.
BofA
$133
2026-10-12
BofA
2026-10-12
目標價
$133
Mizuho
$107
2026-10-07
Mizuho
2026-10-07
目標價
$107
Barclays
$101
2026-10-07
Barclays
2026-10-07
目標價
$101
UBS
$125
2026-10-06
UBS
2026-10-06
目標價
$125
Wells Fargo
$122
2026-08-19
Wells Fargo
2026-08-19
目標價
$122
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Aflac Study Reveals Legacy Planning Gaps for U.S. Workforce

Aflac Study Reveals Legacy Planning Gaps for U.S. Workforce

Brian Jordan Brings Hope to Children with Cancer

Brian Jordan Brings Hope to Children with Cancer

Aflac and Rachel Zoe Launch Cancer Screening Jacket
Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).
Aflac Inc is a good buy right now due to its strong recent performance with a current price of $119.97 and a significant 5-day change of +4.74%. The RSI is at 83.88, indicating strong momentum, while the forward P/E ratio is 15.20, suggesting reasonable valuation compared to growth expectations. However, the main risk is the downgrade from Mizuho, reducing the price target to $107, indicating potential downside.
15 analysts cover AFL: 3 rate it Buy, 10 Hold and 2 Sell. The average price target is 110.90.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。